News & Events about Relmada Therapeutics Inc.
Market News Video
1month ago
In trading on Wednesday, biotechnology shares were relative leaders, up on the day by about 0.4%. Leading the group were shares of Instil Bio, up about 19.7% and shares of Relmada Therapeutics up about 17.4% on the day...
Exchange Traded Concepts LLC lifted its stake in Relmada Therapeutics, Inc. (NASDAQ:RLMD Get Rating) by 278.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,378 shares of the companys stock after purchasing...
Relmada Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11, 2022 Relmada Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11, 2022 PR Newswire CORAL GABLES, Fla., Aug. 5, 2022...
Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial PR Newswire CORAL GABLES, Fla., July 21, 2022 Company...
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028 Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028 PR Newswire PALM BEACH, Fla., May 26, 2022 FinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 26, 2022...